Patent · US Active

Sterile affinity chromatography resin

US10071364B2 · kind B2 · utility

5Cited by
36References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 16, 2015
Grant dateSep 11, 2018
Priority date
Expiry dateJan 16, 2035

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T29/49826
  • WIPO fieldChemical engineering
  • WIPO sectorChemistry

Abstract

Provided herein are methods of reducing bioburden of (e.g., sterilizing) a chromatography resin that include exposing a container including a composition including a chromatography resin and at least one antioxidant agent and/or chelator to a dose of gamma-irradiation sufficient to reduce the bioburden of the container and the chromatography resin, where the at least one antioxidant agent and/or chelator are present in an amount sufficient to ameliorate the loss of binding capacity of the chromatography resin after/upon exposure to the dose of gamma-irradiation. Also provided are reduced bioburden chromatography columns including the reduced bioburden chromatography resin, compositions including a chromatography resin and at least one chelator and/or antioxidant agent, methods of performing reduced bioburden column chromatography using one of these reduced bioburden chromatography columns, and integrated, closed, and continuous processes for reduced bioburden manufacturing of a purified recombinant protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.